Detalhe da pesquisa
1.
Characterization of HOXB13 expression patterns in localized and metastatic castration-resistant prostate cancer.
J Pathol
; 262(1): 105-120, 2024 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37850574
2.
Characterization of structural, biochemical, pharmacokinetic, and pharmacodynamic properties of the LSD1 inhibitor bomedemstat in preclinical models.
Prostate
; 84(10): 909-921, 2024 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-38619005
3.
A Phase II Trial of Intravesical Gemcitabine and Docetaxel in the Treatment of Bacillus Calmette-GuérinâNaïve Nonmuscle-Invasive Urothelial Carcinoma of the Bladder.
J Urol
; : 101097JU0000000000003977, 2024 Apr 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-38653234
4.
Risk of Biochemical Recurrence in Patients With Grade Group 1 Prostate Cancer With Extraprostatic Extension Treated With Radical Prostatectomy.
J Urol
; 211(3): 407-414, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38109699
5.
The Association of Subspecialty and Sex with Industry Payments to Internal Medicine Physicians Who Recently Completed Training.
J Gen Intern Med
; 39(1): 45-51, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-37550442
6.
Presence of cells in the polyaneuploid cancer cell (PACC) state predicts the risk of recurrence in prostate cancer.
Prostate
; 83(3): 277-285, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36372998
7.
ERG Status at the Margin Is Associated With Biochemical Recurrence After Radical Prostatectomy With Positive Surgical Margins.
Mod Pathol
; 36(7): 100147, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-36828362
8.
Predicting Prostate Cancer Molecular Subtype With Deep Learning on Histopathologic Images.
Mod Pathol
; 36(10): 100247, 2023 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-37307876
9.
Clinical Significance of Perineural Invasion in Men With Grade Group 1 Prostate Cancer on Active Surveillance.
J Urol
; 209(1): 180-186, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36073925
10.
Comparison of outcomes of different biopsy schedules among men on active surveillance for prostate cancer: An analysis of the G.A.P.3 global consortium database.
Prostate
; 82(7): 876-879, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35254666
11.
Cell Cycle Progression Score, but Not Phosphatase and Tensin Homolog Loss, Is an Independent Prognostic Factor for Metastasis in Intermediate- and High-risk Prostate Cancer in Men Treated With and Without Salvage Radiotherapy.
J Urol
; 208(6): 1182-1193, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36006048
12.
Timing of Androgen Deprivation Treatment for Men with Biochemical Recurrent Prostate Cancer in the Context of Novel Therapies.
J Urol
; 206(3): 623-629, 2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-34003011
13.
Use of the MyProstateScore Test to Rule Out Clinically Significant Cancer: Validation of a Straightforward Clinical Testing Approach.
J Urol
; 205(3): 732-739, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33080150
14.
Natural history of prostate cancer on active surveillance: stratification by MRI using the PRECISE recommendations in a UK cohort.
Eur Radiol
; 31(3): 1644-1655, 2021 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-33000302
15.
Prostate cancer mortality and metastasis under different biopsy frequencies in North American active surveillance cohorts.
Cancer
; 126(3): 583-592, 2020 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31639200
16.
Urinary Continence Outcomes in Classic Bladder Exstrophy: A Long-Term Perspective.
J Urol
; 203(1): 200-205, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31437120
17.
Older Age Predicts Biopsy and Radical Prostatectomy Grade Reclassification to Aggressive Prostate Cancer in Men on Active Surveillance.
J Urol
; 201(1): 98-104, 2019 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30114397
18.
Reply by Authors.
J Urol
; : 101097JU0000000000004017, 2024 May 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-38713596
19.
20.
Correction to: The Association of Subspecialty and Sex with Industry Payments to Internal Medicine Physicians Who Recently Completed Training.
J Gen Intern Med
; 2024 Feb 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-38383945